Researchers awarded vital funding to explore treatment to slow rare liver disease
LifeArc and PSC Support have jointly awarded £948,774 for new research into primary sclerosing cholangitis (PSC) – a rare disease where the body attacks its own liver, causing inflammation and scar…
Birmingham research shapes new miscarriage guidelines
Research led by BHP founder-member the University of Birmingham has helped to shape guidelines which could mean thousands of women with prior miscarriage, and bleeding in early pregnancy, could be …
New programme to train future mental health and neuroscience professionals
Future healthcare professionals working in mental health and neurosciences will be trained at a new Doctoral Training Programme (DTP) thanks to a multi-million award from Wellcome.
Led by the Univ…
New drug treatment regimen shows promise for patients with lupus
The results of a randomised controlled trial, published in Annals of Internal Medicine, found that a new drug treatment regimen – using belimumab soon after rituximab – reduced a disease-related au…
Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome
A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with pol…
Specific cell population plays key role in effect of arthritis and people’s pain
Research led by scientists at BHP founder-member the University of Birmingham has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the…